Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net income (loss)	$ (3,624,234)	$ (8,370,152)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	18,015,427	17,659,543
(Gain) from investments in real estate-related assets	(80,557)	(49,482)
(Realized Gain) from sale of investment in debt securities	(1,634,920)
Amortization of above-market lease intangibles	98,189	98,189
Amortization of below-market lease intangibles	(978,005)	(978,005)
Unrealized loss from investment in debt securities	454,123
Changes in assets and liabilities:
Proceeds from investments in real estate-related assets	206,473	275,298
(Increase) in deferred rent receivable	(922,618)	(1,206,310)
Decrease/(increase) in prepaid expenses and other assets	1,069,900	(1,898,921)
Increase/(decrease) in due to related parties	4,633,157	(462,715)
Decrease in deferred revenue	9,100	411,227
Increase in restricted reserves	(1,797,802)	(519,234)
(Decrease) in accounts payable and accrued expenses	(1,333,445)	(2,754,376)
(Decrease)/increase in accrued interest payable	(105,661)	102,188
Net cash provided by operating activities	14,009,127	2,307,250
Cash flows from investing activities:
Acquisition of real estate		(412,545)
Capital improvements to real estate	(1,684,236)
Proceeds from sale/repayment of investment in debt securities	10,399,997
Net cash provided by/(used in) investing activities	8,715,761	(412,545)
Cash flows from financing activities:
Borrowings under credit facility	12,000,000	14,000,000
Proceeds from issuance of common stock, net	6,875,030	33,270,125
Distributions	(8,010,182)	(13,174,030)
Payments for redemptions of common stock	(31,754,409)	(23,404,406)
Non-controlling interest distributions	(7,034,093)	(6,880,330)
Non-controlling interest contribution	100,000
Payment of deferred financing costs	(148,807)	(442,790)
Net cash (used in)/provided by financing activities	(27,972,461)	3,368,569
Net increase/(decrease) in cash and cash equivalents and restricted cash	(5,247,573)	5,263,274
Cash and cash equivalents and restricted cash, at beginning of period	39,892,720	38,533,421
Cash and cash equivalents and restricted cash, at end of period	34,645,147	43,796,695
Reconciliation of cash and cash equivalents and restricted cash
Cash and cash equivalents	25,472,948	34,292,465
Restricted cash	9,172,199	9,504,230
Total cash and cash equivalents and restricted cash	34,645,147	43,796,695
Supplemental disclosure of cash flow information:
Cash paid for interest	12,859,619	10,027,725
Non-cash investing and financing activities:
Distribution reinvestment	3,098,283	3,393,475
Distributions payable	1,726,933	1,972,065
Assumption of loans payable in conjunction with acquisitions of real estate		22,500,000
Acquired non-controlling interests	$ (107,225)	$ 19,087,232